M67.20 identifies abnormal thickening of the synovial membrane at an unspecified anatomical site, used when the joint location is not documented or cannot be determined.

Documentation tips

What should appear in the chart to support M67.20.

Source · Editorial brief grounded in 5 cited references ↓

• Specify the affected joint by name in the clinical note — even a single phrase like 'left knee synovial thickening' moves the code from M67.20 to a site-specific M67.2x code.
• Record imaging findings that support synovial hypertrophy (ultrasound, MRI signal changes, or synovial thickness measurement) to substantiate medical necessity and distinguish this from villonodular synovitis (M12.2).
• Document whether the hypertrophy is an isolated finding or associated with an underlying inflammatory arthropathy — if the latter, the underlying condition may need to be coded first.
• Note any prior conservative management (NSAIDs, aspiration, corticosteroid injection) in the record if the visit involves a procedural intervention, to support medical necessity review.
• If the condition involves multiple joints, consider whether M67.29 (multiple sites) is more accurate than the unspecified-site code M67.20.

Related CPT procedures

Procedure codes commonly billed with M67.20. Linking the right diagnosis to the right procedure is what establishes medical necessity.

Source · CMS LCDs · AAOS specialty guidance · claims-pattern analysis

Common coding pitfalls

The recurring mistakes coders make with M67.20 and adjacent codes.

Source · Editorial brief grounded in CDC ICD-10-CM tabular guidance, AAOS coding references, and cited references ↓

• Using M67.20 when the provider documented a specific joint — always map to the site-specific M67.2x subcode; unspecified-site codes invite payer scrutiny and potential downcoding.
• Coding M67.20 instead of M12.2x when the pathology report or MRI confirms pigmented villonodular synovitis — the Excludes1 note at M67.2 prohibits using both codes for the same condition.
• Confusing 'unspecified site' (M67.20) with 'multiple sites' (M67.29) — if the patient has synovial hypertrophy documented at more than one joint, M67.29 is the correct choice.
• Applying M67.20 to tendinitis NOS — tendinitis belongs under M77.9 per the Excludes1 note on parent category M67, not in the synovial hypertrophy subcategory.
• Overlooking MCC/CC capture: when M67.20 is the principal diagnosis, accurately code comorbidities to ensure correct DRG 557 vs. 558 assignment and avoid revenue loss.

Clinical context

Source · Editorial summary grounded in 5 cited references ↓

Sibling codes

Other billable codes under M67.2 (laterality / anatomic variants).